Back to Search
MICHAEL ANDREEFF, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1437263506IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
H9035(TX)
Education
OTHER
Class of 1968
Research & Publications (20)
HOX expression patterns identify a common signature for favorable AML.
PMID 18668134·Leukemia·2008
8-other
Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin.
PMID 18415656·Int J Hematol·2008
8-other
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance.
PMID 19228734·Clin Cancer Res·2009
8-other
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism.
PMID 19258498·Cancer Res·2009
6-review
[Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations].
PMID 19639164·Nuklearmedizin·2009
8-other
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.
PMID 19352430·PLoS One·2009
7-preclinical
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.
PMID 19650040·Stem Cells·2009
7-preclinical
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
PMID 18955566·Blood·2009
7-preclinical
Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.
PMID 19225536·Leukemia·2009
8-other
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
PMID 19211935·Blood·2009
8-other
Cyclin-dependent kinase 1 inhibitor RO-3306 enhances p53-mediated Bax activation and mitochondrial apoptosis in AML.
PMID 19385969·Cancer Sci·2009
8-other
Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
PMID 19458629·Leukemia·2009
7-preclinical
Functional proteomic profiling of AML predicts response and survival.
PMID 18840713·Blood·2009
8-other
CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure.
PMID 18957686·Blood·2009
8-other
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
PMID 19652057·J Clin Oncol·2009
3-trial
Radiosynoviorthesis (RSO): influencing factors and therapy monitoring.
PMID 19039551·Ann Nucl Med·2008
8-other
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe.
PMID 18985472·Cytotherapy·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1437263506
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 58
- Publications
- 20
Are you this provider?
Claim Your Profile